Sivik Global Healthcare’s Agios Pharmaceuticals AGIO Stock Holding History

Sivik Global Healthcare’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-40,000	Closed	-$2.14M	–	41
2020 Q2	$2.14M	Buy	+40,000	New	+$1.85M	0.71%	47
2019 Q3	–	Sell	-30,000	Closed	-$1.5M	–	45
2019 Q2	$1.5M	Buy	30,000 +5,000	+20%	+$267K	0.36%	59
2019 Q1	$1.69M	Buy	25,000 +10,000	+67%	+$582K	0.62%	53
2018 Q4	$692K	Sell	15,000 -5,000	-25%	-$309K	0.37%	45
2018 Q3	$1.54M	Sell	20,000 -5,000	-20%	-$402K	0.55%	55
2018 Q2	$2.11M	Buy	25,000 +4,981	+25%	+$434K	0.81%	48
2018 Q1	$1.64M	Hold	20,019	–	–	0.76%	55
2017 Q4	$1.14M	Buy	+20,019	New	+$1.26M	0.42%	66

Other funds holding AGIO

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sivik Global Healthcare's AGIO Position: Q3 2020 in Review

Sivik Global Healthcare sold out of Agios Pharmaceuticals (AGIO) in Q3 2020, closing a stake of 40,000 shares — an estimated $2.14M sold.

Sivik Global Healthcare first reported a position in AGIO in Q4 2017 and held it in 8 quarters. The position peaked at $2.14M in Q2 2020. 214 funds tracked by Wall St. Rank hold AGIO as of Q3 2020.

Sivik Global Healthcare reported no remaining Agios Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
Sivik Global Healthcare sold 40,000 Agios Pharmaceuticals shares in Q3 2020, an estimated $2.14M.
Sivik Global Healthcare first reported a position in Agios Pharmaceuticals in Q4 2017 and held it in 8 quarters.
Sivik Global Healthcare's Agios Pharmaceuticals position peaked at $2.14M in Q2 2020.
214 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2020.

Based on Sivik Global Healthcare's 13F filing for Q3 2020, filed 13 Nov 2020.